Today’s stock making its way on to our radar is a clinical-stage biopharmaceutical company, which focuses on developing antibody drug conjugates that offer clinical benefit for cancer patients with significant unmet need. Take a look at the 1-year chart of…
Mersana (MRSN) below with added notations:
Chart of MRSN provided by TradingView
MRSN has formed an important area of support around the $6 mark (yellow). The stock has rallied off that zone multiple times in recent months and appears to be falling back down to it again. If the $6 mark were to break, lower prices would likely follow.
The Tale of the Tape: MRSN has key support area around $6. A trader could enter a long position at or around the mark with a stop placed…
Continue reading at WEALTHPOP.com
